đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
The purpose of this study is to demonstrate, in 11-17 year old subjects, th...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-02
Trial ID
NCT00464815
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00196963
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
This study will evaluate the tolerability and immunogenicity of administrat...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-21
Trial ID
NCT00988884
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-27
Trial ID
NCT01340898
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, immuno...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09
Trial ID
NCT00196950
Treatments Being Tested
The purpose of this study is to evaluate the production of antibodies to a ...
Status
Completed
Location
Mid Atlantic Urology Associates LLC
Start Date
2013-07
Trial ID
NCT01897402
Treatments Being Tested